课题基金 / 基金详情

项目摘要

项目成果

Beverly L. Davidson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Gene transfer is becoming increasingly important as a research tool and has clinical potential as well. The Gene Transfer Vector Core (GTVC) brings expertise to cancer from gene transfer experience in multiple other areas of biomedicine. The interaction with multiple investigators from various disciplines and experience with multiple different types of tissues allows for cross-fertilization of ideas, technical advancements, and innovations in vector technologies. The GTVC provides 1) Consultation with the Principal Investigator 2) Development of novel vectors 3) Purified and concentrated preparations of recombinant adenovirus, adeno-associated virus (AAV), and retrovirus (including lentivirus) 4) Collaborative testing of vectors generated for function and purity, and finally routine preparation 5) Standard cell lines, expression plasmids, and stocks of recombinant reporter viruses GTVC staff and investigators are in close contact through all phases of vector design and generation. Thus, the GTVC serves as both a research and development facility for gene transfer studies, and a service facility for routine vector preparations
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROJECT 3: MUCOPOLYSACCHARIDOSIS TYPE 1 (MPS1)
  • 批准号:
    10668620
  • 项目类别:
  • 资助金额:
    $106.93万
  • 财政年份:
    2023
  • 负责人:
    Beverly L. Davidson
  • 依托单位:
Therapeutic APOE2 overexpression for early Alzheimer's disease
  • 批准号:
    10404485
  • 项目类别:
  • 资助金额:
    $180.24万
  • 财政年份:
    2019
  • 负责人:
    Beverly L. Davidson
  • 依托单位:
Therapeutic APOE2 overexpression for early Alzheimer's disease
  • 批准号:
    9922393
  • 项目类别:
  • 资助金额:
    $132.15万
  • 财政年份:
    2019
  • 负责人:
    Beverly L. Davidson
  • 依托单位:
Supplemental Request: Therapeutic APOE2 overexpression for early Alzheimer's disease
  • 批准号:
    10596304
  • 项目类别:
  • 资助金额:
    $139.34万
  • 财政年份:
    2019
  • 负责人:
    Beverly L. Davidson
  • 依托单位:
海外基金